VELSORYA (talverimab) and Avenlith Biopharma are fictional. Every patient profile, product mechanism, trial, efficacy result, safety statistic and regimen is invented for this example.
The lung, airway and alveolar views illustrate simplified educational anatomy. They are not patient scans or experimental structures.
This example is not approved medical content or prescribing information. The device concept is illustrative and provides no instructions for use.